(5R)-5-hydroxytriptolide for HIV immunological non-responders receiving ART: a randomized, double-blinded, placebo-controlled phase II study-Reference-Cited by-同舟云学术

(5R)-5-hydroxytriptolide for HIV immunological non-responders receiving ART: a randomized, double-blinded, placebo-controlled phase II study

Published:2023-05 Issue: Volume:34 Page:100724
ISSN:2666-6065
Container-title:The Lancet Regional Health - Western Pacific
language:en
Short-container-title:The Lancet Regional Health - Western Pacific

Author:

Cao Wei,Liu Xiaosheng^ORCID,Han Yang,Song Xiaojing,Lu Lianfeng,Li Xiaodi,Lin Ling,Sun Lijun,Liu An,Zhao Hongxin,Han Ning,Wei Hongxia,Cheng Jian,Zhu Biao,Wang Min,Li Ying,Ma Ping,Gao Liying,Wang Xicheng,Yu Jianhua,Zhu Ting,Routy Jean-Pierre,Zuo Min,Li Taisheng

Publisher

Elsevier BV

Subject

Infectious Diseases,Psychiatry and Mental health,Geriatrics and Gerontology,Public Health, Environmental and Occupational Health,Obstetrics and Gynecology,Health Policy,Pediatrics, Perinatology and Child Health,Internal Medicine

Reference37 articles.

1. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease;Li;Lancet,1998

2. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease;Autran;Science,1997

3. Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384;Robbins;Clin Infect Dis,2009

4. Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: a cohort study;Engsig;BMC Infect Dis,2010

5. Patients' characteristics and clinical implications of suboptimal CD4 T-cell gains after 1 year of successful antiretroviral therapy;Gutiérrez;Curr HIV Res,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HLA-mismatched allogeneic adoptive immune therapy in patients with severely immunosuppressed AIDS: a multicenter, open-label, controlled, phase 2a study;Emerging Microbes & Infections;2024-06-27

2. Enhanced immune reconstitution with albuvirtide in HIV-infected immunological non-responders;Frontiers in Cellular and Infection Microbiology;2024-06-21

3. LLDT-8 ameliorates experimental autoimmune encephalomyelitis by mediating macrophage functions in the priming stage;European Journal of Pharmacology;2024-01

4. Comprehensive transcriptomic analyses identify the immunosuppressive effects of LLDT-8 in ART-treated SIV-infected rhesus macaques;International Immunopharmacology;2024-01

5. Medicinal patterns of vines used in Chinese herbal medicine: a quantitative study;Journal of Ethnopharmacology;2024-01